Menu X
Industry and Academia
Healthcare Partners
About
Partner with Us
News
Contact Us

Category Archives: Press Release

Novaseek Research Appoints Bennett Malbon as Chief Technology Officer

Company Co-Founder to Lead Technology Strategy and Expansion

CAMBRIDGE, MA, June 15, 2017– Novaseek Research Inc., a health IT for life sciences company, today announced that it has named Bennett Malbon as Chief Technology Officer (CTO) for the company. This is an expansion of Bennett’s current role as Vice President, Technology. As CTO, Bennett will be responsible for driving expansion of Novaseek’s Clinical Data Network for Research (CDNR) platform to meet the evolving needs of biomedical and clinical researchers.

“Novaseek is growing rapidly, and there is a strong need for someone with Bennett’s talent and vision to help drive strategy for the growth and expansion of our CDNR platform,” said Dr. Kate Torchilin, CEO, Novaseek Research. “Bennett has a proven track record of developing comprehensive clinical data solutions for critical needs within the healthcare and life sciences industries. We are excited to have Bennett in this new position.”

“Novaseek is truly innovative in its approach and in the way it enables healthcare organizations and patients to share clinical data and biospecimens for research and provides access for biomedical and clinical researchers to well-categorized patient cohorts for translational and observations studies. I am thrilled to take it to the next level as our team leverages technology to bring better medicines to patients faster,” said Bennett.

Bennett helped found Novaseek Research in 2014, He has more than 20 years of experience in IT and software development. Prior to Novaseek, Bennett was the founding technology architect at Curaspan Health Group, which was acquired by Cardinal Health/NaviHealth in 2016, where he led development and roll-out of a patient transition network electronically connecting 600+ acute care health systems to 8000+ post-acute care providers, payers, and medical transportation services, ultimately handling transitions for approximately 20 percent of acute patients in the U.S.

Additionally, Bennett worked with PatientKeeper where he oversaw platform strategy and architecture for physician portal and workflow tools, and with HealthGrid, an ambulatory EMR referral and data exchange network.

Novaseek’s CDNR is an award-winning, cloud-based platform that provides turn-key access to real world data, patients and biospecimens from a network of healthcare organizations. The CDNR platform enables analysis and prospective observation of well-categorized patient cohorts across multiple disease areas. Researchers access CDNR via an intuitive user interface that gives them the ability to define patient cohorts and request biospecimens with detailed clinical data using population analytics and detailed criteria such as demographics, diagnoses, co-morbidities, lab values, medications and treatment histories.

CDNR makes it possible for Novaseek and its hospital partners to serve complex requests, such as, for example, biospecimens and data collected before and after specific cancer treatments, without the need to burden patients with extra blood draws or complex medical questionnaires. This streamlined approach accelerates research, often cutting out up to 12 months of observational study set up and completion and allows more hospitals and patients to participate in biomedical research.

About CDNR

Novaseek’s award-winning novel cloud platform, the Clinical Data Network for Research (CDNR), easily interfaces with hospital data sources in real time and enables researchers to define patient cohorts through population analytics, and to access consented biospecimens and clinical data to advance translational medicine, clinical development and observational studies.

About Novaseek

Novaseek Research, Inc. is a game-changing health IT for life sciences company that provides turn-key, dynamic access to real world clinical data and biospecimens from a network of healthcare organizations. We envision a world where a clear understanding of real-world patients is central to every stage of life sciences research and drug development. For more information, please visit www.novaseekresearch.com.

Media Contact:

Terri Clevenger
Continuum Health Communications
tclevenger@continuumhealthcom.com
(203) 856-4326

Novaseek Research is Named Top 10 Clinical Data Management Solution Provider

CAMBRIDGE, MA, May 25, 2017– Novaseek Research Inc., a health IT for life sciences company, today announced that it was awarded the Top 10 Clinical Data Management Solution Provider 2017 award by Pharma Tech Outlook. The award recognizes 10 companies at the forefront of providing clinical data management solutions for the pharmaceutical industry and impacting the marketplace.

“Novaseek Research stands out for its solution, the Clinical Data Network for Research (CDNR) platform, that is at the forefront of tackling challenges and is among the leading companies that are real trailblazers in creating benchmarks to be followed,” said Max Wilson, editorial team, Pharma Tech Outlook.

Novaseek Research was selected for the Top 10 Clinical Data Management Solution Provider Award by a panel of experts and members of Pharma Tech Outlook’s editorial board.

“We are honored to be recognized as a cutting-edge clinical data management solution provider by Pharma Tech Outlook,” said Dr. Kate Torchilin, CEO, Novaseek Research. “Through our CDNR platform, Novaseek is seeking to leverage the power of real world clinical data to facilitate getting better medicines to patients faster.”

CDNR is an award-winning, cloud-based platform that transforms the way healthcare organizations and consented patients share biospecimens and clinical data with the research community. Researchers access CDNR via an intuitive user interface that gives them the ability to define patient cohorts and request biospecimens using population analytics and detailed criteria such as demographics, diagnoses, co-morbidities, lab values, medications and treatment histories.

The CDNR makes it possible for Novaseek and its hospital partners to serve complex requests, such as, for example, biospecimens and data collected before and after specific cancer treatments, without the need to burden patients with extra blood draws or complex medical questionnaires. This streamlined approach accelerates research and allows more hospitals and patients to participate in supporting biomedical research.

Novaseek was featured in the May 2017 edition of Pharma Tech Outlook. Click here for access to the print article and here for access to the online version.

About CDNR

Novaseek’s award-winning novel cloud platform, the Clinical Data Network for Research (CDNR), easily interfaces with hospital data sources in real time and enables researchers to define patient cohorts through population analytics and to access consented biospecimens and clinical data to advance translational medicine, clinical development and observational studies.

About Novaseek

Novaseek Research, Inc. is a game-changing health IT for life sciences company that provides turn-key, dynamic access to real world clinical data and biospecimens from a network of healthcare organizations. We envision a world where a clear understanding of real-world patients is central to every stage of life sciences research and drug development. For more information, please visit www.novaseekresearch.com.

Media Contact:

Terri Clevenger
Continuum Health Communications
tclevenger@continuumhealthcom.com
(203) 856-4326

Novaseek Research Announces Partnership with CoxHealth to Advance Biomedical and Clinical Research

Partnership with Missouri Health System Further Expands Access to Biospecimens and Dynamic Real World Data for Research

CAMBRIDGE, MA, April 13, 2017 (GLOBE NEWSWIRE) – Novaseek Research Inc, a health IT for life sciences company, today announced it has partnered with CoxHealth, one of the nation’s top 100 integrated health systems, to support and expand biomedical and clinical research activity. Through this collaboration, CoxHealth and Novaseek will utilize Novaseek’s Clinical Data Network for Research (CDNR) platform to procure, with patient consent and authorization, biospecimens and associated real world clinical data in pursuit of accelerating medical innovation. The agreement also expands Novaseek’s national network of healthcare organizations that supports discovery, translational medicine, observational and clinical studies.

“Novaseek is excited to partner with CoxHealth, one of the largest hospital systems in Missouri and surrounding states,” said Dr. Kate Torchilin, Chief Executive Officer, Novaseek Research. “Novaseek’s objective is to aid researchers in developing better medicine based on better understanding of patients. We also want to help healthcare organizations like CoxHealth balance research engagement with their core mission of providing patient care, as well as giving an opportunity for patients to participate in research.”

CDNR is an award-winning, cloud-based platform that transforms the way healthcare organizations share biospecimens and clinical data with the research community. The platform constantly scans for laboratory biospecimens that match researchers’ detailed clinical criteria, automating what was once a manual process of biospecimen selection and chart reviews. Researchers access CDNR via an intuitive user interface that gives them the ability to define patient cohorts and request biospecimens using population analytics and detailed criteria such as demographics, diagnoses, co-morbidities, lab values, medications and treatment histories. The CDNR makes it possible for Novaseek and its hospital partners to serve complex requests, such as, for example, biospecimens and data collected before and after specific cancer treatments, without the need to burden patients with extra blood draws or complex medical questionnaires. This streamlined approach accelerates research and allows more hospitals and patients to participate in supporting biomedical research.

“In 2016, CoxHealth was recognized as a ‘Most Wired’ hospital by Hospitals & Health Networks magazine, based on how hospitals across the country are adopting information technology to improve patient care. This same ‘most wired’ philosophy is why we so are excited to employ CDNR to better serve our patients who are interested in participating in research and clinical studies,” said Chris Schulze, Director, Clinical Research, CoxHealth. “Through our partnership with Novaseek Research, we are able to expand our patients’ range of options and enable them to participate in advancing scientific research. This collaboration strengthens CoxHealth’s position as one of the most widely recognized hospitals in our region.”

Since launching in 2014, Novaseek has assembled a national network of hospital partners and is enabling its growing research customer base to access real world clinical data and biospecimens in a novel way and to bring medical advances to patients faster.

About CDNR

Novaseek’s award-winning novel cloud platform, the Clinical Data Network for Research (CDNR), easily interfaces with hospital data sources in real time and enables researchers to define patient cohorts through population analytics and to access consented biospecimens and data to advance translational medicine, clinical development and observational studies.

About CoxHealth

A community-based, not-for-profit health system, CoxHealth is headquartered in Springfield, Mo., and is nationally accredited by DNV GL – Healthcare. Established in 1906, the organization serves more than 900,000 people in a 24-county service area in southwest Missouri and northwest Arkansas, offering a comprehensive array of primary and specialty care including five hospitals and more than 80 clinics in 25 communities. The health system includes Cox Medical Center South, Cox Medical Center Branson, Cox North Hospital, Meyer Orthopedic and Rehabilitation Hospital, Cox Monett Hospital, Oxford HealthCare, Home Parenteral Services (home infusion therapy), CoxHealth Foundation, Cox College, Cox HealthPlans and more.

About Novaseek

Novaseek Research, Inc. is a game-changing health IT for life sciences company that provides turn-key, dynamic access to real world clinical data and biospecimens from a network of healthcare organizations. We envision a world where a clear understanding of real-world patients is central to every stage of life sciences research and drug development. For more information, please visit www.novaseekresearch.com.

Media Contact:

Terri Clevenger
Continuum Health Communications
tclevenger@continuumhealthcom.com
(203) 856-4326

Novaseek Research Announces Important Feature Enhancements to CDNR Platform for Biologically-Enhanced Real World Data

— Biospecimens enriched with deep data insights for population analytics, prospective patient tracking and more —

CAMBRIDGE, MA, Jan. 9, 2017– Novaseek Research LLC today announced that its Clinical Data Network for Research (CDNR) platform was recently enhanced to include the capability to dynamically collect biospecimens and clinical data from patients during the course of the disease or treatment, as well as with population analytics features that enable researchers to draw insights into the effect of various co-morbidities or drug classes on the progression of the disease. Novaseek offers researchers turnkey solutions for accessing biospecimens from consented patients with associated, detailed clinical data and dynamic real world data for prospective and longitudinal observational studies.

“The evolution of medicine and initiatives such as the Personalized Medicine Initiative, the Cancer Moonshot and the guidance in the 21 st Century Cures Act make the need for real world data more compelling than ever before,” said Dr. Kate Torchilin, CEO of Novaseek. “However, until recently there were no effective tools to obtain and utilize real world data in life sciences R&D. CDNR was built with the specific needs of the researcher in mind to enable dynamic data and biospecimen collection. The data available through CDNR can be combined with prospective access to biospecimens at different stages of disease or treatment to give a complete picture of the patient.”

The CDNR platform is cloud-based and does not require any installation. Its massive historical clinical data supports population analytics based on detailed criteria such as demographics, primary diagnosis and co-morbidities, lab test results, medications, and clinical procedures, and can aid in the discovery, development and post-launch stages of R&D. Researchers access the platform via an award-winning, intuitive user interface to define patient cohorts, request biospecimens, query data and track for updates.

CDNR supports research across multiple therapeutic areas, including oncology, immuno-oncology, CNS, immunology, neuroscience, cardiovascular/metabolic and more.

“We recently reached a milestone of one million patient encounters and are poised to at least triple our impact in 2017. CDNR offers researchers an unprecedented depth of insight through biospecimens and patient-level data, dynamic monitoring of consented patient cohorts and population analytics,” said Bennett Malbon, Vice President, Technology, Novaseek Research.

Since its launch, Novaseek has grown its clients base to include three of the world’s top 10 largest pharmaceutical companies, several biotechnology companies as well as researchers in academia.

About Novaseek

Novaseek Research LLC is a game-changing health IT for life sciences company that transforms how biomedical researchers access clinical data and human biospecimens for real world data and observational studies. Novaseek powers speedy and successful discovery, translational medicine and real world data studies by enabling access to dynamic and longitudinal data and biospecimens via its award-winning Clinical Data Network for Research (CDNR) cloud platform. We envision a world where a clear understanding of real-world patients is central to every stage of life sciences research and drug development. For more information, please visit www.novaseekresearch.com.

Media Contact:

Terri Clevenger
Continuum Health Communications
tclevenger@continuumhealthcom.com
(203) 856-4326

Novaseek Research to Present at Digital Medicine Showcase 2017

BOSTON, Dec. 13, 2016– Novaseek Research LLC, a health information technology for life sciences company, today announced that Kate Torchilin, PhD, MBA, Chief Executive Officer, will present at the upcoming Digital Medicine Showcase 2017, which takes place concurrently with the JP Morgan 35th Annual Healthcare Conference in San Francisco. Dr. Torchilin’s presentation will take place at 2:15 PM Pacific on Tuesday, January 10, at the Parc 55 San Francisco – Union Square.

In her presentation, Dr. Torchilin will provide an overview of Novaseek’s Clinical Data Network for Research (CDNR) platform and discuss how CDNR enables researchers turnkey access to clinical data and data-enriched, consented human biospecimens for use in real-world data and translational medicine studies in the areas of oncology, immune-oncology, cardiovascular disease, diabetes, neuroscience and more. She also will share how CDNR helps researchers define patient cohorts through population analytics and supports historical and longitudinal tracking and the collection of biospecimens and associated clinical data to stratify patients for studies.

About Novaseek

Novaseek Research LLC is a game-changing health IT for life sciences company that transforms how biomedical researchers access clinical data and human biospecimens for real-world data and precision medicine studies. Novaseek powers speedy and successful discovery, translational medicine, and real-world data studies by providing easy access to patients, longitudinal patient data and biospecimens via its award-winning Clinical Data Network for Research (CDNR) SaaS platform. We envision a world where a clear understanding of real-world patients is central to every stage of life sciences research and drug development. For more information, please visit www.novaseekresearch.com.

Media Contact:

Terri Clevenger
Continuum Health Communications
tclevenger@continuumhealthcom.com
(203) 856-4326